Recent advances in gestational trophoblastic neoplasia

Current Diagnostic Pathology

Volumn 13, Issue 3, 2007, Pages 210-221

  Sebire, N J ^a   Lindsay, I ^a   Fisher, R A ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Complete mole; Gestational trophoblastic neoplasia; Hydatidiform mole; Partial mole; Trophoblast

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CHORIOCARCINOMA; ECTOPIC PREGNANCY; FAMILIAL DISEASE; GENETIC ANALYSIS; GENOTYPE; HISTOPATHOLOGY; HUMAN; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; MATERNAL AGE; PLACENTA DEVELOPMENT; PREGNANCY COMPLICATION; SPONTANEOUS ABORTION; TROPHOBLASTIC TUMOR; TWIN PREGNANCY;

EID: 34250722784     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdip.2007.04.005     Document Type: Article

References (65)

1. Tidy JA, Hancock BW, Newlands ES. The management of gestational trophoblastic neoplasia. Royal College of Obstetricians and Gynaecologists Guideline, number 38, February 2004.
2. Sebire N.J., Fisher R.A., and Rees H.C. Histopathological diagnosis of partial and complete hydatidiform mole in the first trimester of pregnancy. Pediatr Dev Pathol 6 (2003) 69-77
3. Sebire N.J., Makrydimas G., Agnantis N.J., Zagorianakou N., Rees H., and Fisher R.A. Updated diagnostic criteria for partial and complete hydatidiform moles in early pregnancy. Anticancer Res 23 (2003) 1723-1728
4. Seckl M.J., Fisher R.A., Salerno G., et al. Choriocarcinoma and partial hydatidiform moles. Lancet 356 (2000) 36-39
5. Sebire N.J., Foskett M., Fisher R.A., Lindsay I., and Seckl M.J. Persistent gestational trophoblastic disease is rarely, if ever, derived from non-molar first-trimester miscarriage. Med Hypotheses 64 (2005) 689-693
6. Kim S. Epidemiology. In: Hancock B.W., Newlands E.S., and Berkowitz R.S. (Eds). Gestational trophoblastic disease (1997), Chapman & Hall, London 27-42
7. Bagshawe K.D., Dent J., and Webb J. Hydatidiform mole in England and Wales 1973-83. Lancet 2 (1986) 673-677
8. Sebire N.J., Fisher R.A., Foskett M., Rees H., Seckl M.J., and Newlands E.S. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. Br J Obstet Gynaecol 110 (2003) 22-26
9. Bracken M.B. Incidence and aetiology of hydatidiform mole: an epidemiological review. Br J Obstet Gynaecol 94 (1987) 1123-1135
10. Sebire N.J., Foskett M., Fisher R.A., Rees H., Seckl M., and Newlands E.S. Risk of partial and complete hydatidiform mole in relation to maternal age. Br J Obstet Gynaecol 109 (2002) 99-102
11. Kajii T., and Ohama K. Androgenetic origin of hydatidiform mole. Nature 268 (1977) 633-634
12. Jacobs P.A., Hunt P.A., Matsuura J.S., Wilson C.C., and Szulman A.E. Complete and partial hydatidiform mole in Hawaii: cytogenetics, morphology and epidemiology. Br J Obstet Gynaecol 89 (1982) 258-266
13. Lawler S.D., Povey S., Fisher R.A., and Pickthall V.J. Genetic studies on hydatidiform moles. II. The origin of complete moles. Ann Hum Genet 46 (1982) 209-222
14. Fisher R.A., Povey S., Jeffreys A.J., Martin C.A., Patel I., and Lawler S.D. Frequency of heterozygous complete hydatidiform moles, estimated by locus-specific minisatellite and Y chromosome-specific probes. Hum Genet 8 (1989) 259-263
15. Fisher R.A., Hodges M.D., and Newlands E.S. Familial recurrent hydatidiform mole: a review. J Reprod Med 49 (2004) 595-601
16. Szulman A.E., and Surti U. The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations. Am J Obstet Gynecol 131 (1978) 665-671
17. Lawler S.D., Fisher R.A., Pickthall V.J., Povey S., and Evans M.W. Genetic studies on hydatidiform moles. I. The origin of partial moles. Cancer Genet Cytogenet 5 (1982) 309-320
18. Jacobs P.A., Szulman A.E., Funkhouser J., Matsuura J.S., and Wilson C.C. Human triploidy: relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole. Ann Hum Genet 46 (1982) 223-231
19. Zaragoza M.V., Surti U., Redline R.W., Millie E., Chakravarti A., and Hassold T.J. Parental origin and phenotype of triploidy in spontaneous abortions: predominance of diandry and association with the partial hydatidiform mole. Am J Hum Genet 66 (2000) 1807-1820
20. Vejerslev L.O., Fisher R.A., Surti U., and Wake N. Hydatidiform mole: Cytogenetically unusual cases and their implications for the present classification. Am J Obstet Gynecol 157 (1987) 180-184
21. Surani M.A., Barton S.C., and Norris M.L. Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature 308 (1984) 548-550
22. Barton S.C., Surani M.A., and Norris M.L. Role of paternal and maternal genomes in mouse development. Nature 311 (1984) 374-376
23. Sebire N.J., Rees H., Paradinas F., et al. Extravillus endovascular implantation site trophoblast invasion is abnormal in complete versus partial molar pregnancies. Placenta 22 (2001) 725-728
24. Fisher R.A., Paradinas F.J., Soteriou B.A., Foskett M., and Newlands E.S. Diploid hydatidiform moles with fetal red blood cells in molar villi. 2-genetics. J Pathol 181 (1997) 189-195
25. Shih I.M., and Kurman R.J. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol 20 (2001) 31-47
26. Saxena A., Frank D., Panichkul P., Van den Veyver I.B., Tycko B., and Thaker H. The product of the imprinted gene IPL marks human villous cytotrophoblast and is lost in complete hydatidiform mole. Placenta 24 (2003) 835-842
27. KIP2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest 78 (1998) 269-276
28. KIP2. Am J Surg Pathol 25 (2001) 1225-1230
29. KIP2 to assist molar classification. J Reprod Med 47 (2002) 342-346
30. Fisher R.A., Hodges M.D., Rees H.C., et al. The maternally transcribed gene p57(KIP2) (CDNK1C) is abnormally expressed in both androgenetic and biparental complete hydatidiform moles. Hum Mol Genet 11 (2002) 3267-3272
31. Fukunaga M. Immunohistochemical characterization of p57(KIP2) expression in early hydatidiform moles. Hum Pathol 33 (2002) 1188-1192
32. KIP2 in hydatidiform mole and its clinical implication. J Huazhong Univ Sci Technol Med Sci 22 (2002) 121-122
33. KIP2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles. Histopathology 43 (2003) 17-25
34. KIP2 immunohistochemistry. Histopathology 43 (2003) 363-373
35. Kip2 expression in tetraploid hydropic placentas. Arch Pathol Lab Med 128 (2004) 897-900
36. KIP2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses. Hum Pathol 36 (2005) 180-186
37. Romaguera R.L., Rodriguez M.M., Bruce J.H., et al. Molar gestations and hydropic abortions differentiated by p57 immunostaining. Fetal Pediatr Pathol 23 (2004) 181-190
38. KIP2. J Reprod Med 50 (2005) 307-312
39. Fisher R.A., and Newlands E.S. Rapid diagnosis and classification of hydatidiform moles using the polymerase chain reaction. Am J Obstet Gynecol 168 (1993) 563-569
40. Osada H., Iitsuka Y., Matsui H., and Sekiya S. A complete hydatidiform mole coexisting with a normal fetus was confirmed by variable number tandem repeat (VNTR) polymorphism analysis using polymerase chain reaction. Gynecol Oncol 56 (1995) 90-93
41. Makrydimas G., Sebire N.J., Thornton S.E., Zagorianakou N., Lolis D., and Fisher R.A. Complete hydatidiform mole and normal live birth: a novel case of confined placental mosaicism: case report. Hum Reprod 17 (2002) 2459-2463
42. Kovacs B.W., Shahbahrami B., Tast D.E., and Curtin J.P. Molecular genetic analysis of complete hydatidiform moles. Cancer Genet Cytogenet 54 (1991) 143-152
43. Helwani M.N., Seoud M., Zahed L., Zaatari G., Khalil A., and Slim R. A familial case of recurrent hydatidiform molar pregnancies with biparental genomic contribution. Hum Genet 105 (1999) 112-115
44. Sensi A., Gualandi F., Pittalis M.C., et al. Mole maker phenotype: possible narrowing of the candidate region. Eur J Hum Genet 8 (2000) 641-644
45. Hodges M.D., Rees H.C., Seckl M.J., Newlands E.S., and Fisher R.A. Genetic refinement and physical mapping of a biparental complete hydatidiform mole locus on chromosome 19q13.4. J Med Genet 40 (2003) e95
46. Panichkul P.C., Al-Hussaini T.K., Sierra R., et al. Recurrent biparental hydatidiform mole: additional evidence for a 1.1-Mb locus in 19q13.4 and candidate gene analysis. J Soc Gynecol Investig 12 (2005) 376-383
47. Zhao J., Moss J., Sebire N.J., Cui Q.C., Seckl M.J., Xiang Y., et al. Analysis of the chromosomal region 19q13.4 in two Chinese families with recurrent hydatidiform mole. Hum Reprod 21 (2006) 536-541
48. Fisher R.A., Khatoon R., Paradinas F.J., Roberts A.P., and Newlands E.S. Repetitive complete hydatidiform mole can be biparental in origin and either male or female. Hum Reprod 15 (2000) 594-598
49. Judson H., Hayward B.E., Sheridan E., and Bonthron D.T. A global disorder of imprinting in the human female germ line. Nature 416 (2002) 539-542
50. El-Maarri O., Seoud M., Riviere J.B., et al. Patients with familial biparental hydatidiform moles have normal methylation at imprinted genes. Eur J Hum Genet 13 (2005) 486-490
51. Moglabey Y.B., Kircheisen R., Seoud M., El Mogharbel N., Van den Veyver I., and Slim R. Genetic mapping of a maternal locus responsible for familial hydatidiform moles. Hum Mol Genet 8 (1999) 667-671
52. Murdoch S., Djuric U., Mazhar B., et al. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet 38 (2006) 300-302
53. Slim R., Fallahian M., Riviere J.B., and Zali M.R. Evidence of a genetic heterogeneity of familial hydatidiform moles. Placenta 26 (2005) 5-9
54. Berkowitz R.S., and Goldstein D.P. Presentation and management of molar pregnancy. In: Hancock B.W., Newlands E.S., and Berkowitz R.S. (Eds). Gestational trophoblastic disease (1997), Chapman & Hall, London 127-142
55. Gemer O., Segal S., Kopmar A., and Sassoon E. The current clinical presentation of complete molar pregnancy. Arch Gynecol Obstet 264 (2000) 33-34
56. Fowler D.J., Lindsay I., Seckl M.J., and Sebire N.J. Routine pre-evacuation ultrasound diagnosis of hydatidiform mole: experience of more than 1000 cases from a regional referral center. Ultrasound Obstet Gynecol 27 (2006) 56-60
57. Sebire N.J., Foskett M., Paradinas F.J., et al. Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin. Lancet 359 (2002) 2165-2166
58. Cohen M.C., Roper E.C., Sebire N.J., Stanek J., and Anumba D.O. Placental mesenchymal dysplasia associated with fetal aneuploidy. Prenat Diagn 25 (2005) 187-192
59. Surti U., Hill L.M., Dunn J., Prosen T., and Hoffner L. Twin pregnancy with a chimeric androgenetic and biparental placenta in one twin displaying placental mesenchymal dysplasia phenotype. Prenat Diagn 25 (2005) 1048-1056
60. Kaiser-Rogers K.A., McFadden D.E., Livasy C.A., et al. Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia. J Med Genet 43 (2006) 187-192
61. Burton J.L., Lidbury E.A., Gillespie A.M., et al. Over-diagnosis of hydatidiform mole in early tubal ectopic pregnancy. Histopathology 38 (2001) 409-417
62. Sebire N.J., Lindsay I., Fisher R.A., Savage P., and Seckl M.J. Overdiagnosis of complete and partial hydatidiform mole in tubal ectopic pregnancies. Int J Gynecol Pathol 24 (2005) 260-264
63. Gillespie A.M., Lidbury E.A., Tidy J.A., and Hancock B.W. The clinical presentation, treatment, and outcome of patients diagnosed with possible ectopic molar gestation. Int J Gynecol Cancer 14 (2004) 366-369
64. Terada S., Suzuki N., Uchide K., and Akasofu K. Partial hydatidiform mole in the fallopian tube. Gynecol Obstet Invest 35 (1993) 240-242
65. Sebire N.J., Lindsay I., Fisher R.A., and Seckl M.J. Intraplacental choriocarcinoma: experience from a tertiary referral center and relationship with infantile choriocarcinoma. Fetal Pediatr Pathol 24 (2005) 21-29